Position in ADCT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,027
-$40,469 QoQ
Shares Held
14,044
-5.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 113 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $31,211,469 across 27 Drug Manufacturers - Specialty & Generic names. ADCT ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,096 | $7,839,638 | |
| 2 | PRGO |
PERRIGO Co plc
|
632,256 | $6,569,139 | |
| 3 | VTRS |
Viatris Inc
|
236,959 | $3,762,908 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3,067 | $1,661,792 | |
| 5 | ALKS |
Alkermes plc.
|
29,373 | $1,539,145 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
37,512 | $1,300,541 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
11,126 | $1,234,318 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
7,264 | $1,224,274 |
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,027 | 14,044 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $55,496 | 14,799 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $55,516 | 15,727 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $49,552 | 12,388 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $39,811 | 14,855 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $24,823 | 17,605 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $45,572 | 22,901 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,402 | 15,366 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||